Intertrochanteric Femoral Fracture Fixation Trial

Status Active, not recruiting

Clinical Trial Summary

The main goal of the study is to determine which cephalomedullary nail results in a better functional outcome for the patient with an unstable intertrochanteric hip fracture. Subjects will be randomized to fixation with either a Gamma3 cephalomedullary nail or an InterTan cephalomedullary nail. Outcomes will be reviewed over a 12 month follow-up period.

Clinical Trial Description

Primary Hypotheses:

Patients who maintain their initial fracture reduction and subsequent position over time with minimal femoral neck shortening and varus will demonstrate significantly improved functional abilities, including gait and abductor function.

Secondary Objective:

- Whether radiographic differences in femoral neck shortening and varus collapse translate into a worse functional outcome to the patient.

- Whether there are differences in mortality between treatments

- Whether there is a time frame follow up after which there is no difference in outcomes.

- Evaluate the device used for fracture stabilization as a potentially contributing factor for maintenance of normal or near-normal abductor function and gait.

Primary Outcome:

The primary outcome will be functional abilities at 3, 6 and 12 months after injury. The following measures of functional ability will be utilized:

Methods:

This is a prospective, randomized non-blinded study. Patients will be identified as they present to the orthopaedic trauma service of Tampa General Hospital with a qualifying injury to determine their interest in participating in the study. Written informed consent will be obtained prior to initiation of any study procedures.

Group A will undergo cephalomedullary nail-based single screw intertrochanteric hip fracture fixation device (Gamma 3 nail). Group B will receive the integrated dual screw intertrochanteric hip fracture fixation device (Intertan nail). Patient outcomes will be analyzed using intention to treat principles. Following randomization assignment, surgeons will all follow the identical described surgical technique, with the only variable being the implant used. Post-operative immobilization and time to weight bearing and rehabilitation protocols will be again identical for all patients regardless of fixation technique. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02627040
Study type	Interventional
Source	Florida Orthopaedic Institute
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 30, 2015
Completion date	September 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02422355` - A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures
Completed	`NCT02197065` - Pilot Study of Atorvastatin for Orthopedic Surgery Patients	Phase 2
Recruiting	`NCT01934946` - Rehabilitation Care for Hip Fracture	N/A
Completed	`NCT01714336` - Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?	Phase 4
Terminated	`NCT01667913` - Reliability of 6-Minutes Walking Test in Hip Fracture Patients	N/A
Terminated	`NCT01535781` - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?	N/A
Completed	`NCT01174589` - Training of Patients With Hip Fracture	Phase 2
Active, not recruiting	`NCT02362971` - External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture	N/A
Completed	`NCT02591342` - Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture	N/A
Completed	`NCT01382875` - The Comparison of Comprehensive Multi-disciplinary Program and Conventional Care Program on Fragility Fracture Elderly	Phase 3
Completed	`NCT01738776` - Nutritional Risk Factors for Hip Fracture: a Case Control Study	N/A
Suspended	`NCT00521716` - Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation	N/A
Terminated	`NCT00128115` - Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)	Phase 2
Active, not recruiting	`NCT00345488` - Fast Track Admittance of Hip Fracture Patients	Phase 4
Completed	`NCT02409082` - Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures	N/A
Recruiting	`NCT04626934` - Cognitive Intervention and Rehabilitation Outcomes in Hip Fracture Patients	N/A
Completed	`NCT06001996` - Comparison of Intraoperative- Postoperative Effects of Pericapsular Nerve Block and Fascia Iliaca Block in Hip Fracture
Recruiting	`NCT02635763` - Peripheral Nerve Blocks in Elderly Patients With Hip Fracture	N/A
Completed	`NCT02190903` - A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia	N/A
Completed	`NCT00848913` - Strength Training After Hip Fracture Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.